GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 8 filers reported holding GLAXOSMITHKLINE PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $252,000 | -0.8% | 5,850 | 0.0% | 0.14% | -5.5% |
| Q2 2016 | $254,000 | -94.1% | 5,850 | -94.5% | 0.15% | -93.9% |
| Q1 2016 | $4,292,000 | -3.2% | 105,835 | -3.7% | 2.41% | -3.9% |
| Q4 2015 | $4,436,000 | +5.7% | 109,945 | +0.8% | 2.51% | +1.9% |
| Q3 2015 | $4,195,000 | -9.2% | 109,100 | -1.7% | 2.46% | +2.8% |
| Q2 2015 | $4,622,000 | -11.7% | 110,970 | -2.2% | 2.40% | -10.0% |
| Q1 2015 | $5,234,000 | +6.5% | 113,420 | -1.4% | 2.66% | +13.8% |
| Q4 2014 | $4,916,000 | -11.3% | 115,020 | -4.6% | 2.34% | -9.4% |
| Q3 2014 | $5,540,000 | -9.4% | 120,520 | +5.4% | 2.58% | -4.8% |
| Q2 2014 | $6,117,000 | -3.1% | 114,380 | -3.2% | 2.71% | -1.9% |
| Q1 2014 | $6,314,000 | -2.3% | 118,175 | -2.4% | 2.77% | -0.9% |
| Q4 2013 | $6,464,000 | +6.6% | 121,075 | +0.2% | 2.79% | +0.0% |
| Q3 2013 | $6,064,000 | -1.0% | 120,875 | -1.3% | 2.79% | -4.5% |
| Q2 2013 | $6,123,000 | – | 122,525 | – | 2.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |